Bonalive

Bonalive is a Finnish company based in Turku, specializing in smart biomaterials for innovative healthcare solutions. Founded in 2009, Bonalive focuses on transforming the treatment of infections, particularly bone infections, without the use of antibiotics. Their core product, Bonalive® granules, is a unique bioactive glass biomaterial that inhibits bacterial growth and is officially indicated for filling bone cavities in chronic osteomyelitis treatment. This technology has a strong clinical history and has been successfully applied in various surgical fields. The company aims to enhance patient wellbeing and improve recovery times while reducing procedural complexity for medical professionals. Bonalive serves both adult and pediatric patients and has expanded its reach internationally, with subsidiaries in Germany, Italy, and the United States, and products available in around 40 countries. Committed to addressing antimicrobial resistance, Bonalive invests in education and collaboration among healthcare professionals, hosting symposiums and training sessions to promote the use of bioactive glass solutions.

• Employees 40
• Founded 2009
• Annual Revenue $5000000